Paper33285232
Regulatory mechanisms of Sesn2 and its role in multi-organ diseases.
Wang B J and 7 others. Pharmacol Res, 2021. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Regulatory mechanisms of Sesn2 and its role in multi-organ diseases. Papers, record 33285232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33285232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nuclear Proteins | Major topic |
| Animals | |
| Heart Diseases | |
| Humans | |
| Kidney Diseases | |
| Respiratory Tract Diseases | |
| Stress, Physiological | |
| Vascular Diseases | |
| Sestrins |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866843 | SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis. | Transl Androl Urol | 2026 | https://conductscience.org/library/papers/42866843 | PubMed |
| 42467600 | Verapamil Reduces Collagen Synthesis to Alleviate Ureteral Scar Formation by Inhibiting KDM1A-Mediated Epigenetic Silencing of SESN2. | Kidney Blood Press Res | 2026 | https://conductscience.org/library/papers/42467600 | PubMed |
| 41614860 | Sestrin2 Knockdown Impairs Proliferation, Migration, Invasion, and Apoptosis in OSCC Cells via PI3K/AKT/mTOR and MAPK Pathways. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41614860 | PubMed |
| 41281654 | Lactoferrin-cyanidin-3-glucoside nanoparticles alleviate inflammation and oxidative stress via Sesn2/Nrf2 activation in mastitis. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41281654 | PubMed |
| 41077348 | MK8722 alleviates osteoarthritis by activating Sesn2 and transcriptionally upregulating BNIP3 to promote mitophagy and inhibit chondrocyte ferroptosis. | J Adv Res | 2026 | https://conductscience.org/library/papers/41077348 | PubMed |
| 40775338 | SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis. | J Transl Med | 2025 | https://conductscience.org/library/papers/40775338 | PubMed |
| 40485171 | Direct scavenging of ROS by S-PPE NP reduces oxidative stress-induced stimulation of the SESN2/AMPK/KIM-1 pathway in acute kidney injury. | Ren Fail | 2025 | https://conductscience.org/library/papers/40485171 | PubMed |
| 40433409 | Association of plasma levels of Sestrin2 with adiposity and metabolic function indices in healthy and diabetic subjects from Qatar Biobank. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40433409 | PubMed |
| 40009261 | Aerobic Exercise Activates Fibroblast Growth Factor 21 and Alleviates Cardiac Ischemia/Reperfusion-induced Neuronal Oxidative Stress and Ferroptosis in Paraventricular Nucleus. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40009261 | PubMed |
| 39443993 | SETDB1 targeting SESN2 regulates mitochondrial damage and oxidative stress in renal ischemia-reperfusion injury. | BMC Biol | 2024 | https://conductscience.org/library/papers/39443993 | PubMed |
| 39343295 | The mechanism and therapeutic strategies in doxorubicin-induced cardiotoxicity: Role of programmed cell death. | Cell Stress Chaperones | 2024 | https://conductscience.org/library/papers/39343295 | PubMed |
| 38254953 | A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/38254953 | PubMed |
| 38163459 | Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis. | Mol Metab | 2024 | https://conductscience.org/library/papers/38163459 | PubMed |
| 37920252 | Sestrin2 in diabetes and diabetic complications. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37920252 | PubMed |
| 36035135 | Identification of Ferroptosis-Related Molecular Clusters and Immune Characterization in Autism Spectrum Disorder. | Front Genet | 2022 | https://conductscience.org/library/papers/36035135 | PubMed |
| 36010689 | Targeting on Nrf2/Sesn2 Signaling to Rescue Cardiac Dysfunction during High-Fat Diet-Induced Obesity. | Cells | 2022 | https://conductscience.org/library/papers/36010689 | PubMed |
| 34979914 | The functions and roles of sestrins in regulating human diseases. | Cell Mol Biol Lett | 2022 | https://conductscience.org/library/papers/34979914 | PubMed |
| 34829679 | OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34829679 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SESN2 | 83667 | PubTator's text mining | https://conductscience.org/library/genes/83667 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33285232
GET https://conductscience.org/api/papers/v1/33285232/authors